MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mantey, S.
Right arrow Articles by Jensen, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mantey, S.
Right arrow Articles by Jensen, R. T.

Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes

S Mantey, H Frucht, DH Coy and RT Jensen

Cell Biology Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Bombesin (Bn)-related peptides affect numerous cell functions; however, receptor characterization by radiolabeled ligands is limited because only radiolabeled agonists exist. In the present study we demonstrate that [D-Tyr6]Bn(6-13)methyl ester [[D-Tyr6]Bn(6-13)ME] functions as a Bn receptor antagonist with high affinity. The binding of both the radiolabeled agonist 125I-[Tyr4]Bn and the radiolabeled antagonist 125I- [D-Tyr6]Bn(6-13)ME to AR42J cells, murine 3T3 cells, and dispersed guinea pig pancreatic acini was time and temperature dependent, saturable, and reversible. Binding of the antagonist more rapidly reached equilibrium and was more rapidly reversible. Guanine nucleotides did not affect binding of the radiolabeled antagonist, whereas guanosine-5'-(beta,gamma-imido)triphosphate decreased agonist binding by decreasing Bn receptor affinity. Acid stripping studies demonstrated that the radiolabeled agonist, but not the antagonist, was internalized in each cell system. Bn receptor affinities for various Bn receptor agonists or antagonists in each cell system were identical when computed from an analysis of inhibition curves for binding of radiolabeled agonist or antagonist. However, with AR42J cells and 3T3 cells the radiolabeled agonist demonstrated a > 2-fold higher number of Bn receptors than did the radiolabeled antagonist. Binding studies using cell membranes, in contrast to cells, showed equal numbers of Bn receptors with either radiolabeled ligand. The radiolabeled agonist demonstrated high affinity binding to both rat pancreatic acinar and esophageal muscularis mucosa membranes, whereas the radiolabeled antagonist interacted with high affinity only with the gastrin- releasing peptide-preferring subtype of Bn receptors on pancreatic tissue. These results demonstrate that 125I-[D-Tyr6]Bn(6-13)ME is a high affinity radiolabeled antagonist that interacts specifically with Bn receptors. In contrast to the radiolabeled agonist, binding of the antagonist is not affected by guanine nucleotides and it is not internalized, which allows quantitation of only Bn cell surface receptors. Furthermore, the radiolabeled antagonist can distinguish Bn receptor subtypes, whereas the radiolabeled agonist does not. This ligand should prove useful for characterizing Bn receptors as well as studying their regulation.

Volume 43, Issue 5, pp. 762-774, 05/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
JNMHome page
T. Maina, B. A. Nock, H. Zhang, A. Nikolopoulou, B. Waser, J.-C. Reubi, and H. R. Maecke
Species Differences of Bombesin Analog Interactions with GRP-R Define the Choice of Animal Models in the Development of GRP-R-Targeting Drugs
J. Nucl. Med., May 1, 2005; 46(5): 823 - 830.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. J. Kim, B. M. Evers, D. A. Litvak, M. R. Hellmich, and C. M. Townsend Jr.
Signaling mechanisms regulating bombesin-mediated AP-1 gene induction in the human gastric cancer SIIA
Am J Physiol Cell Physiol, August 1, 2000; 279(2): C326 - C334.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. S. Kroog, X. Jian, L. Chen, J. K. Northup, and J. F. Battey
Phosphorylation Uncouples the Gastrin-releasing Peptide Receptor from Gq
J. Biol. Chem., December 17, 1999; 274(51): 36700 - 36706.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Jian, E. Sainz, W. A. Clark, R. T. Jensen, J. F. Battey, and J. K. Northup
The Bombesin Receptor Subtypes Have Distinct G Protein Specificities
J. Biol. Chem., April 23, 1999; 274(17): 11573 - 11581.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Y. Williams, S. B. Dion, and A. Schonbrunn
Role of Receptor and Protein Kinase C Activation in the Internalization of the Gastrin-Releasing Peptide Receptor
Mol. Pharmacol., November 1, 1998; 54(5): 889 - 898.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. L. Hampton, E. E. Ladenheim, M. Akeson, J. M. Way, H. C. Weber, V. E. Sutliff, R. T. Jensen, L. J. Wine, H. Arnheiter, and J. F. Battey
Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice
PNAS, March 17, 1998; 95(6): 3188 - 3192.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. R. Hellmich, J. F. Battey, and J. K. Northup
Selective reconstitution of gastrin-releasing peptide receptor with Galpha q
PNAS, January 21, 1997; 94(2): 751 - 756.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-J. Tseng, S. Coon, E. Stuenkel, V. Struk, and C. D. Logsdon
Influence of Second and Third Cytoplasmic Loops on Binding, Internalization, and Coupling of Chimeric Bombesin/m3 Muscarinic Receptors
J. Biol. Chem., July 28, 1995; 270(30): 17884 - 17891.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics